69ÈÈÊÓƵ

We’ve moved

The Rosalind and Morris Goodman Cancer Institute can now be found at

Ìý

George Zogopoulos, M.D., Ph.D.

Academic title(s): 

Associate Professor/Professeur Associé
Rosalind and Morris Goodman Cancer Institute
Departments Oncology and Surgery
Research Institute of the 69ÈÈÊÓƵ Health Centre (RI-MUHC)
Faculty of Medicine and Health Sciences
69ÈÈÊÓƵ

Hepato-Pancreato-Biliary and Abdominal Organ Transplant Surgery
Division of General Surgery
69ÈÈÊÓƵ Health Centre (MUHC)

George Zogopoulos, M.D., Ph.D.
Contact Information
Address: 

1160 Pine Avenue West
Montreal, Quebec H3A 1A3
Lab: Room 611
Ìý

Office: 69ÈÈÊÓƵ Health Centre,ÌýEM2.3210,Ìý1001Decarie Blvd., Montreal, Quebec, H4A 3J1

Phone: 
514-934-1934, ext. 36306
Fax number: 
514-843-1434
Email address: 
george.zogopoulos [at] mcgill.ca
Awards, honours, and fellowships: 

1. 2016ÌýClinical Research Scholar (Junior 2),ÌýFonds de recherche du Québec – Santé

2. 2012ÌýClinical Research Scholar (Junior 1),ÌýFonds de recherche du Québec – Santé

Selected publications: 

Ìý

Current research: 

Dr.ÌýZogopoulos’ lab studies the genetics and oncogenomics of pancreaticobiliary cancers. His research includes discovery of genetic associations with familial pancreatic cancer, and therapeutic opportunities for pancreaticobiliary cancers driven by homologous recombination deficiency.

To pursue his research interests, Dr.ÌýZogopoulosÌýestablished and directs the Quebec Pancreas Cancer Study (QPCS), a familial patient registry and biospecimen repository for pancreatic, biliary tract and peri-ampullary malignancies. His program’s resources also include patient-derived tumour xenograft and cell-line libraries.

His translational research program is integrated into the ambulatory oncology clinics at the 69ÈÈÊÓƵ Health Centre to facilitate access to genetic counseling and testing as well as precision oncology and early detection opportunities for patients with pancreaticobiliary cancers.

Dr.ÌýZogopoulosÌýis the Pancreatic Disease Oriented Group co-Chair of the Canadian Cancer Trials Group (CCTG), and his research activities also include theÌýpan-CanadianÌýPancreatic Cancer Profiling for Individualized Care (EPPIC) study, theÌýQuebec Consortium for Novel Cancer Therapeutics and Biomarkers, theÌýPancreatic Cancer Genetic Epidemiology (PACGENE) consortium, and the Pancreatic Cancer Early Detection (PRECEDE) consortium.

His clinical practice focuses on the surgical treatment of pancreatic, biliary and hepatic malignancies, as well as abdominal organ transplantation with a focus on transplant oncology.Ìý

Back to top